New immunotherapy combo aims to stop colorectal cancer relapse
Disease control
Recruiting now
This study tests whether immunotherapy drugs (cemiplimab alone or with fianlimab) can clear leftover cancer DNA in the blood of colorectal cancer patients after surgery and chemotherapy. About 79 adults with stage II/III colon or rectal cancer who still have cancer DNA markers wi…
Phase: PHASE2 • Sponsor: NSABP Foundation Inc • Aim: Disease control
Last updated Jun 05, 2026 12:07 UTC